Special methods of magnetic resonance in diagnosis of multiple sclerosis.
https://doi.org/10.18705/2782-3806-2024-4-1-12-18
EDN: YLKHPZ
Abstract
The article is devoted to the review of the most promising MRI techniques in the diagnosis of multiple sclerosis as part of personalized medicine. A brief description of the current state of the problem is provided. Examples of promising MR research techniques are considered. The issues of clinical importance and expediency of using these techniques are discussed. The existing approaches in the diagnosis of multiple sclerosis are summarized. In conclusion, the prospects and importance of the considered methods in the structure of healthcare are summarized.
About the Authors
I. A. Turchinskaya
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Turchinskaya Irina A., resident of the Department of Radiation Diagnostics and medical imaging with the clinic Almazov National Medical Research Centre
Akkuratova str., 2, Saint Petersburg, 19734
S. R. Sheriev
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Sheriev Sultan R., resident of the Department of Radiation Diagnostics and medical imaging with the clinic Almazov National Medical Research Centre
Akkuratova str., 2, Saint Petersburg, 19734
A. Yu. Efimtsev
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Efimtsev Aleksandr Yu., PhD, Associate Professor of Radiation Diagnostics and Medical Imaging Department, leading researcher of Radiation Diagnostics Research Laboratory, Almazov National Medical Research Centre. Leading Researcher of the Research Laboratory of Radiation Imaging, Leading Researcher of the Group for Personalized Treatment of Postmastectomy Syndrome, World-Class Research Centre for Personalized Medicine
Akkuratova str., 2, Saint Petersburg, 19734
G. E. Trufanov
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Trufanov Gennadiy E., MD, PhD, professor, chief researcher of the Radiation Diagnostics Research Department, head of Radiation Diagnostics and Medical Imaging Department, Almazov National Medical Research Centre
Akkuratova str., 2, Saint Petersburg, 19734
References
1. Кротенкова И.А. и др. Магнитно-резонансная томография в диагностике рассеянного склероза // Академия медицины и спорта. 2021. Т. 2. №. 3. С. 17–24.
2. Walton C, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS // Multiple Sclerosis Journal. 2020. Vol. 26. No. 14. P. 1816–1821.
3. Qian Z, et al. Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019 //Frontiers in Public Health. 2023. Vol. 11. P. 1073278.
4. Boski N, et al. Multiple sclerosis-minimizing errors in radiological diagnosis //Neurology India. 2021. Vol. 69. No. 6. P. 1539.
5. Смирнов В.С. и др. Магнитно-резонансная томография в диагностике рассеянного склероза. 2023.
6. Капканец Д.В. и др. Признак парамагнитного обода при рассеянном склерозе //Неврология, нейропсихиатрия, психосоматика. 2023. Т. 15. №. 4. С. 94–99.
7. Solomon AJ, et al. Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria //Multiple Sclerosis Journal. 2021. Vol. 27. No. 2. P. 250–258.
8. Filippi M, et al. Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study //Neurology. 2022. Vol. 98. No. 1. P. e1–e14.
9. Wattjes MP, et al. 2021 MAGNIMS–CMSC– NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis //The Lancet Neurology. 2021. Vol. 20. No. 8. P. 653–670.
10. Богдан А.А. Изменение функционального состояния вещества головного мозга при рассеянном склерозе по данным протонной магнитно-резонансной спектроскопии. Санкт-Петербург, 2021.
11. Filippi M, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines //Brain. 2019. Vol. 142. No. 7. P. 1858–1875.
12. De Stefano N, et al. MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies //NeuroImage: Clinical. 2022. Vol. 34. P. 102972.
13. Kolb H, et al. From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions //NeuroImage: Clinical. 2022. P. 103194.
14. Saslow L, et al. An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis: advocacy, dissemination, and implementation strategies // International journal of MS care. 2020. Vol. 22. No. 5. P. 226–232.
15. Алиханов А.А., Шимановский Н.Л. Фармако-экономическая оценка применения одно-молярного гадолиний-содержащего магнитно-резонансного контрастного препарата по сравнению с полу-молярными препаратами для диагностики рассеянного склероза //Вестник рентгенологии и радиологии. 2020. Т. 101. №. 5. С. 306–314.
16. Сашин Д.В. и др. Возможности магнитно-резонансной томографии в режиме SwI в дифференциальной диагностике глиом (g3-g4) и первичных лимфом головного мозга //Опухоли головы и шеи. 2020. Т. 10. №. 2. С. 38–45.
17. Белов С.Е. и др. Симптом центральной вены при разных заболеваниях и протоколах МРТ-исследования //Журнал неврологии и психиатрии имени С. С. Корсакова. 2022. Т. 122. №. 7. Вып. 2. С. 19–26.
18. Meaton I, et al. Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis //Multiple Sclerosis Journal. 2022. Vol. 28. No. 14. P. 2212–2220.
19. Barker PB. Brain Pathology in Multiple Sclerosis with High-Field-Strength MR Spectroscopic Imaging //Radiology. 2022. Vol. 303. No. 1. P. 151–152.
Review
For citations:
Turchinskaya I.A., Sheriev S.R., Efimtsev A.Yu., Trufanov G.E. Special methods of magnetic resonance in diagnosis of multiple sclerosis. Russian Journal for Personalized Medicine. 2024;4(1):12-18. (In Russ.) https://doi.org/10.18705/2782-3806-2024-4-1-12-18. EDN: YLKHPZ
Views:
136
Email this article 